Barbee Whitaker1, Srijana Rajbhandary2, Steven Kleinman3, Andrea Harris2, Naynesh Kamani4. 1. Department of Research, AABB, Bethesda, Maryland. bwhitaker@aabb.org. 2. Department of Research, AABB, Bethesda, Maryland. 3. Senior Medical Advisor, AABB, Bethesda, Maryland. 4. Center for Cellular Therapies & Research, AABB, Bethesda, Maryland.
Abstract
BACKGROUND: AABB surveyed AABB institutional members about their 2013 blood collection, transfusion, and patient blood management (PBM) programs. Results were compared with previous US national surveys. STUDY DESIGN AND METHODS: The 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey was distributed to AABB blood centers (79) and hospitals (1068). Statistical procedures were used to estimate blood collection and transfusion. RESULTS: Estimated whole blood (WB) and red blood cell (RBC) collections in 2013 totaled 13.6 million units, a 12.1% decrease from 15.5 million units in 2011 (p < 0.0001). Transfusions of WB and RBC units by AABB hospitals totaled 6.1 million units, 7.3% fewer compared to 2011 (p = 0.036). There was no change in overall platelet (PLT) distributions by blood collectors but WB-derived (WBD) PLT distributions increased significantly (27.1%, p < 0.0001). Transfusion of PLTs increased 15.4% totaling 1.3 million units (p = 0.0423), including increases in apheresis PLT (12.2%) and WBD PLT transfusions (30.7%). Distribution of plasma for transfusion declined 22.4% (p < 0.0001), while transfused plasma decreased only 9.9% (p = 0.036). Hospitals reduced outdated WB, RBC, and PLT components by 14.9% to 26.1% and wasted plasma components by 19.0%. PBM programs were reported by 37.8% of AABB hospitals. CONCLUSIONS: Compared to 2011, WB and RBC collections declined significantly in 2013 and disproportionately to the significant reductions in WB and RBC transfusions. Distributions of PLTs and plasma for transfusion declined in 2013, as did transfusions of plasma, while transfusion of PLTs increased significantly. Decreases in outdated and wasted components by hospitals suggest improvements in product and inventory management. Ongoing national surveys allow for trend analysis and are important for future planning.
BACKGROUND: AABB surveyed AABB institutional members about their 2013 blood collection, transfusion, and patient blood management (PBM) programs. Results were compared with previous US national surveys. STUDY DESIGN AND METHODS: The 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey was distributed to AABB blood centers (79) and hospitals (1068). Statistical procedures were used to estimate blood collection and transfusion. RESULTS: Estimated whole blood (WB) and red blood cell (RBC) collections in 2013 totaled 13.6 million units, a 12.1% decrease from 15.5 million units in 2011 (p < 0.0001). Transfusions of WB and RBC units by AABB hospitals totaled 6.1 million units, 7.3% fewer compared to 2011 (p = 0.036). There was no change in overall platelet (PLT) distributions by blood collectors but WB-derived (WBD) PLT distributions increased significantly (27.1%, p < 0.0001). Transfusion of PLTs increased 15.4% totaling 1.3 million units (p = 0.0423), including increases in apheresis PLT (12.2%) and WBD PLT transfusions (30.7%). Distribution of plasma for transfusion declined 22.4% (p < 0.0001), while transfused plasma decreased only 9.9% (p = 0.036). Hospitals reduced outdated WB, RBC, and PLT components by 14.9% to 26.1% and wasted plasma components by 19.0%. PBM programs were reported by 37.8% of AABB hospitals. CONCLUSIONS: Compared to 2011, WB and RBC collections declined significantly in 2013 and disproportionately to the significant reductions in WB and RBC transfusions. Distributions of PLTs and plasma for transfusion declined in 2013, as did transfusions of plasma, while transfusion of PLTs increased significantly. Decreases in outdated and wasted components by hospitals suggest improvements in product and inventory management. Ongoing national surveys allow for trend analysis and are important for future planning.
Authors: Kasiemobi E Pulliam; Bernadin Joseph; Rosalie A Veile; Lou Ann Friend; Amy T Makley; Charles C Caldwell; Alex B Lentsch; Michael D Goodman; Timothy A Pritts Journal: J Trauma Acute Care Surg Date: 2020-10 Impact factor: 3.313
Authors: Nareg H Roubinian; Jeanne E Hendrickson; Darrell J Triulzi; Jerome L Gottschall; Michael Michalkiewicz; Dhuly Chowdhury; Daryl J Kor; Mark R Looney; Michael A Matthay; Steven H Kleinman; Donald Brambilla; Edward L Murphy Journal: Crit Care Med Date: 2018-04 Impact factor: 7.598
Authors: Lise J Estcourt; Reem Malouf; Marialena Trivella; Dean A Fergusson; Sally Hopewell; Michael F Murphy Journal: Cochrane Database Syst Rev Date: 2017-01-27
Authors: John M Gansner; Mahboubeh Rahmani; A Helena Jonsson; Brooke M Fortin; Idayat Brimah; Martha Ellis; Robin Smeland-Wagman; Zhihan J Li; Jason M Schenkel; Michael B Brenner; Revital Yefidoff-Freedman; Steven R Sloan; Nancy Berliner; Nicolas C Issa; Lindsey R Baden; Dan L Longo; Duane R Wesemann; Donna Neuberg; Deepak A Rao; Richard M Kaufman Journal: Blood Date: 2018-11-14 Impact factor: 22.113
Authors: Christopher R France; Janis L France; Bruce W Carlson; Victoria Frye; Louisa Duffy; Debra A Kessler; Mark Rebosa; Beth H Shaz Journal: Contemp Clin Trials Date: 2016-12-12 Impact factor: 2.226
Authors: Francesca Rapido; Gary M Brittenham; Sheila Bandyopadhyay; Francesca La Carpia; Camilla L'Acqua; Donald J McMahon; Abdelhadi Rebbaa; Boguslaw S Wojczyk; Jane Netterwald; Hangli Wang; Joseph Schwartz; Andrew Eisenberger; Mark Soffing; Randy Yeh; Chaitanya Divgi; Yelena Z Ginzburg; Beth H Shaz; Sujit Sheth; Richard O Francis; Steven L Spitalnik; Eldad A Hod Journal: J Clin Invest Date: 2016-12-12 Impact factor: 14.808
Authors: Sofie L Rygård; Andreas B Jonsson; Martin B Madsen; Anders Perner; Lars B Holst; Pär I Johansson; Jørn Wetterslev Journal: Intensive Care Med Date: 2018-01-25 Impact factor: 17.440